Clinical trials
Withdrawn Phase 2 Waldenstrom Macroglobulinemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2014 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoag Memorial Hospital Presbyterian | 3 |
| Academic and Community Cancer Research United | 1 |
| Burzynski Research Institute | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| SWOG Cancer Research Network | 1 |
| University of California, San Francisco | 1 |
| University of Medicine and Dentistry of New Jersey | 1 |
| University of Texas Southwestern Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Waldenstrom Macroglobulinemia | 10 |
| Lymphoma | 7 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
| Lymphoma, B-Cell, Marginal Zone | 6 |
| Lymphoma, Follicular | 6 |
| Lymphoma, Mantle-Cell | 5 |
| Lymphoma, Non-Hodgkin | 5 |
| Burkitt Lymphoma | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoma, Large-Cell, Immunoblastic | 4 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.